2021 Winner - Dr. Anca Prica Wednesday, April 28, 2021 Dr. Ralph Meyer Phase III Young Investigator Award Congratulations from everyone at CCTG, The Ralph Meyer Young Investigator Award was presented to Dr Prica at the Annual Spring Meeting last week. The award hours MD, fellow, PhD within 10 years of certification / first faculty appointment or current fellow who has either spent time at CCTG Central Office, worked on Phase III projects with Disease Site Committees / Endpoint Committees / Working Groups, or who has contributed significantly to the conduct of a Phase III trial at a centre. 2021 Winner - Dr. Anca Prica Dr. Prica is a staff hematologist at Princess Margaret Cancer Centre and assistant professor in the division of hematology at University of Toronto. She is currently the site lead of the lymphoma and myeloma program at Princess Margaret Cancer Centre. She did her initial medical training in Toronto and her clinical training in Internal Medicine and Hematology in the University of Toronto Program. She completed a 2- year fellowship in Malignant Hematology at the Sunnybrook Health Sciences Centre and a Masters in Health Research Methodology at McMaster University with research interests in quality of life and economic evaluations. Her clinical work focuses in both lymphoproliferative and plasma cell disorders, as well as autologous stem cell transplantation and CAR-T therapy. Her research interests focus on health services research, particularly economic evaluations, and decision analyses for oncologic questions examining resource use and cost of care, as well as toxicity of chemotherapies and their effects on quality of life and caregiver burden. She is a member of the Committee for Economic Analysis and the Quality of Life Committee within the CCTG, as well as the Hematology Disease Site Group. “I am shocked and so honoured to be the recipient of the Ralph Meyer Phase III Young Investigator Award. The illustrious company of the previous winners is humbling. The ability to get involved with the Hematology Disease site group, Committee for Economic analysis and Quality of Life Committee and participate in and lead projects has been one of the highlights of my career so far. I am thankful to numerous CCTG colleagues who have involved and sponsored me, particularly Dr. Matt Cheung, Dr. Annette Hay, Dr. Michael Crump, Dr. Lois Shepherd, and Dr. Nicole Mittman. Thank you again for this huge honour and I look forward to ongoing involvement with the group.”
